Arsenic (13 oxidation state) methyltransferase (As3mt) catalyzes methylation of inorganic arsenic (iAs) producing a number of methylated arsenic metabolites. Although methylation has been commonly considered a pathway for detoxification of arsenic, some highly reactive methylated arsenicals may contribute to toxicity associated with exposure to inorganic arsenic. Here, adult female wild-type (WT) C57BL/6 mice and female As3mt knockout (KO) mice received drinking water that contained 1, 10, or 25 ppm (mg/l) of arsenite for 33 days and blood, liver, kidney, and lung were taken for arsenic speciation. Genotype markedly affected concentrations of arsenicals in tissues. Summed concentrations of arsenicals in plasma were higher in WT than in KO mice; in red blood cells, summed concentrations of arsenicals were higher in KO than in WT mice. In liver, kidney, and lung, summed concentrations of arsenicals were greater in KO than in WT mice. Although capacity for arsenic methylation is much reduced in KO mice, some mono-, di-, and tri-methylated arsenicals were found in tissues of KO mice, likely reflecting the activity of other tissue methyltransferases or preabsorptive metabolism by the microbiota of the gastrointestinal tract. These results show that the genotype for arsenic methylation determines the phenotypes of arsenic retention and distribution and affects the dose-and organdependent toxicity associated with exposure to inorganic arsenic.
Chronic exposure to high levels of arsenic (As) has been linked with increased risk of skin, bladder, and lung cancers as well as adverse health effects including hypertension, cardiovascular effects, and skin keratosis (Chen et al., 1992; Chiou et al., 1995; Chiu et al., 2004; Das et al., 1995; Navas-Acien et al., 2005; Yoshida et al., 2004) . Drinking water is the most common source of human exposure to inorganic arsenic (iAs) (Cullen and Reimer, 1989; Oremland and Stolz, 2003) . In humans and many other species, ingested iAs is quickly transformed to methylated metabolites, which are excreted in urine. For example, mono-and dimethylated arsenicals are the predominant arsenicals found in urine of humans after ingestion of iAs-contaminated drinking water (Cullen and Reimer, 1989; Hopenhayn-Rich et al., 1996; Vahter, 1983) . Formation of methylated arsenicals has long been regarded as a means for detoxification of iAs (Vahter, 1983) . However, some methylated metabolites of iAs are more potent cytotoxicants and disruptors of cell signaling pathways than iAs (Charoensuk et al., 2009; Mass et al., 2001; Paul et al., 2007; Petrick et al., 2000; Stýblo et al., 2000) . Thus, the pathway for methylation is probably best regarded as consisting of both detoxifying and activating processes.
Methylation of As involves a series of reactions in which the oxidation state of As is reduced from pentavalency to trivalency, and trivalent As is oxidatively methylated (Challenger, 1951) . These reactions are catalyzed by a cytosolic enzyme, arsenic (þ3 oxidation state) methyltranferase (As3mt), which uses S-adenosylmethionine (AdoMet) as a methyl group donor and requires a dithiol-containing reductant (e.g., thioredoxin) for activity . Occurrences of orthologous As3mt genes in genomes of organisms as diverse as sea urchins (Strongylocentrotus purpuratus) and Homo sapiens strongly correlate with As methylation phenotype (Li et al., 2005; Thomas et al., 2007) . Heterologous expression of rat As3mt in human uroepithelial cells confers As methylation capacity in cells that do not constitutively methylate As . Conversely, RNA interference with As3mt gene expression in HepG2 hepatoma cells diminishes cellular As methylation (Drobná et al., 2006 ). An As3mt knockout (KO) mouse model has been used to study the role of As methylation in the disposition and toxicity of As. In As3mt KO mice, an altered As methylation phenotype changes the tissue distribution of arsenicals and markedly reduces the rate of whole body clearance of As (Drobná et al., 2009; Hughes et al., 2010) . This phenotypic change in As3mt KO mice exacerbates systemic toxicity and the effects of arsenite on the urinary bladder epithelium demonstrating linkages among As methylation, tissue distribution and retention, and toxicity (Yokohira et al., 2010) .
This study examined tissue distribution of iAs and its methylated metabolites in adult female wild-type (WT) and As3mt KO mice that received 1, 10, or 25 ppm of arsenite (As   III   ) in drinking water for 33 days. This exposure regimen has been associated with uroepithelial cell injury and regenerative hyperplasia in As3mt KO mice (Yokohira et al., 2010) . Altered tissue distribution of iAs and its metabolites in As3mt KO mice may be a useful tool for study of the role of methylation in the toxic and carcinogenic effects associated with exposure to iAs and for determining modes of action for various metabolites formed during methylation.
MATERIALS AND METHODS
Chemicals. Arsenic standard stock solutions (1000 mg As/l) for speciation analysis of As were prepared by dissolving appropriate amounts of sodium arsenite (As III ; Sigma, St Louis, MO), sodium arsenate (As V ; Sigma), dimethyl arsinic acid (DMA V ; Aldrich), trimethylarsine oxide (TMAO V ; Tri Chemical Laboratories Inc.), and monomethylarsonic acid (MMA V ; Chem Service) in deionized water. Working solutions were prepared daily by serial dilutions of stock solutions.
As3mt KO mice. Male and female mice homozygous for the disrupted As3mt gene (Drobná et al., 2009) were initially produced at the U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, and transferred to an AAALAC-accredited facility at the University of Nebraska Medical Center. Because As3mt KO mice are fertile, brother-sister matings produced As3mt KO mice for this study. The mice had free access to diet (autoclaved pelleted Teklad 7012 diet designed for rodent breeding, Harlan Teklad, Madison, WI) and water (hyperchlorinated and reverse osmosis [RO], As level < 5 ppb) ad libitum. During mating, one male was housed with one to two females. When pregnancy was apparent, the pregnant females were separated from the male and housed individually. Pups were weaned at 21 days of age or later and housed based on dam and sex.
Animal exposure. Twenty-eight female WT C57BL/6 mice (Charles River Laboratories, Raleigh, NC), 8-week old at the time of arrival, were placed in an AAALAC-accredited facility and quarantined for 8 days before treatment. C57BL/6 mice are WT with respect to As3mt gene expression and serve as controls for comparison to As3mt KO mice. Twenty-eight female As3mt KO mice from the F2 generation, approximately 9 to 11 weeks old, were transferred from the breeding colony to the same room with WT mice. The level of care provided to the animals met or exceeded the basic requirements outlined in the Guide for the Care and Use of Laboratory Animals (National Institutes of Health [NIH] Publication #86-23, revised 1986). Mice were provided free access to pelleted Purina 5002 rodent chow (Dyets Inc., Bethlehem, PA) and water (hyperchlorinated, RO) until the beginning of the exposure phase of this study.
At approximately 9-12 weeks of age, animals were randomized into four treatment groups per genotype (seven per group) using a weight stratification method (Martin et al., 1986) . Groups 1 to 4 were composed of As3mt KO mice, and groups 5 to 8 were WT mice. For treatment, drinking water was changed from hyperchlorinated RO water to tap water (As level < 5 ppb) amended with sodium arsenite. Groups 1 and 5 were provided tap water with no test substance added, groups 2 and 6 were treated with 1.73 ppm sodium arsenite (1 ppm As III ), groups 3 and 7 were treated with 17.3 ppm sodium arsenite (10 ppm As III ), and groups 4 and 8 were treated with 43.3 ppm sodium arsenite (25 ppm As III ). Freshly prepared NaAsO 2 -containing drinking water was provided to mice every Monday and Thursday. Drinking water for control (untreated) mice was provided on the same schedule.
One animal in group 4 was sacrificed on study day 29 due to moribundity. Approximately half of the remaining mice were sacrificed on study day 33 (two each As3mt KO and WT control mice, four mice per treatment group) and the other half on day 34 (two each As3mt KO and WT control mice, three mice in treatment group 4, and four mice per remaining treatment groups). Although the mice were sacrificed over a 2-day period, we refer to the administration time as 33 days, recognizing that half the mice received treatment for 34 days. All animals were sacrificed by an overdose of Nembutal (150 mg/kg body weight) and exsanguination. While the animals were under deep anesthesia, but prior to exsanguination and death, blood was obtained by cardiac puncture and transferred to a prechilled lithium heparin-containing tube. Plasma and red blood cells (RBC) were separated by centrifugation at 3000 rpm at 4°C for 10 min, and each fraction was flash frozen in liquid N 2 . Liver, kidneys, and lungs were removed, and the liver and kidneys were weighed. Tissues were not perfused to remove blood. A section from the left lung, the whole left kidney, and a section of the upper lobe of the liver were placed in separate prechilled cryovials and flash frozen in liquid N 2 . Samples were stored at À20°± 5°C for approximately 6 days before overnight shipment on dry ice from Omaha to Edmonton for analysis.
Sample preparation for As speciation. Plasma samples were thawed at room temperature and thoroughly vortex mixed. Thirty microliter aliquots of plasma were mixed with 30 ll hydrogen peroxide (H 2 O 2 , 30%, Fisher Scientific, Canada) and 50 ll deionized water. Mixtures were held at room temperature overnight. An aliquot of 30 ll was injected to high performance liquid chromatography inductively coupled plasma mass spectrometry (HPLC-ICP-MS) for As speciation analysis.
RBC samples were thawed at room temperature, and about 20 mg of material was weighed into a 2 ml centrifuge tube and lysed by addition of 1 ml 10mM ammonium bicarbonate (Fluka) and 0.02% (vol/vol) ammonia aqueous solution (Fisher Scientific). RBC lysates were centrifuged at 12,000 rpm at 4°C for 10 min. One hundred microliter aliquots of supernatants were mixed with 100-ll hydrogen peroxide (H 2 O 2 , 30%, Fisher Scientific) and 200 ll deionized water. The mixtures were held at room temperature overnight. An aliquot of 50 ll was used for As speciation analysis.
Liver and kidney samples (0.2-0.3 g) were homogenized in 1 ml of deionized water. Aliquots of homogenates (0.15 ml) were mixed with 2.5 ml of 2M phosphoric acid (Fluka, 85%, Switzerland). Lung samples were weighed and directly homogenized in 2.5 ml of 2M phosphoric acid. Mixtures were heated overnight in a water bath at 90°C. Digestates were filtered through 0.45 lm membranes (Mandel) and diluted five times with deionized water for HPLC-ICP-MS analysis.
Identification and quantification of As species by HPLC-ICP-MS. An Agilent 1100 series HPLC system including a pump, degasser, autosampler, and anion exchange column (Hamilton, PRP-X100, 150 3 4.1 mm, 5 lm particle size) was used for separation of arsenicals. A PRP-X100 guard column cartridge (20 3 2.3 mm) was mounted before the analytical column for protection. The mobile phase contained 35mM ammonium bicarbonate and 5% methanol (HPLC grade, Fisher Scientific) adjusted to pH 8.5. The column was equilibrated with mobile phase for at least 0.5 h at a flow rate of 0.8 ml/min. A step flow gradient program for separation consisted of 0.8 ml/min for the initial 4 min followed by 1.4 ml/min for the subsequent 11 min.
Following speciation separation, the effluent from HPLC was introduced directly into the nebulizer of an Agilent 7500ce octopole reaction system ICP-MS (Agilent Technologies, Japan) using polyetheretherketone (PEEK) tubing. ICP-MS was operated with a helium mode. Use of helium (3.5 ml/min) in the octopole reaction cell reduced isobaric and polyatomic interference. The ICP was operated at a radio frequency power of 1550 W, and the flow rate of the ARSENIC METABOLISM AND TISSUE DOSIMETRY 321 argon carrier gas was 0.9-1.0 l/min. Arsenic was monitored at m/z 75. Chromatograms from HPLC separations were recorded with an ICP-MS ChemStation (Agilent Technologies, Santa Clara, CA). Because samples were pretreated with hydrogen peroxide, the oxidation state of As in inorganic or methylated species cannot be determined. Hence, values for inorganic and methylated arsenicals are sums of trivalent and pentavalent As-containing species present in tissue samples. The detection limit of ICP-MS for all arsenic species is 0.1 ng/ml. Statistical analysis. Summed tissue arsenical concentrations were calculated as sums of each arsenical quantified in a tissue sample. The percentages of methylated arsenicals were calculated as the tissue concentration of mono-, di-, and trimethylated arsenicals divided by summed tissue arsenical concentration. Differences in tissue concentrations of summed arsenicals and relative percentage concentration of methylated arsenicals between WT and As3mt KO mice at each dose level were evaluated by one-way ANOVA with means comparison of Bonferroni using OriginPro 8.0 software (OriginLab Corporation). These analyses focused mainly on phenotypic differences in arsenic metabolism as related to As3mt genotype. Differences at the p < 0.05 level (95% confidence interval [CI]) were considered statistically significant. Figure 1 shows absolute concentrations and relative fractional concentrations of arsenicals in plasma and RBCs of WT and As3mt KO mice that received 1-25 ppm of As III in drinking water for 33 days. For both genotypes, summed arsenical concentrations in plasma were dosage dependent (Fig. 1a) . Summed arsenical concentrations in plasma from WT mice treated with 25 ppm As III were about 7-fold higher than summed arsenical concentrations in WT mice treated with 1 ppm As III . By comparison, the summed arsenical concentrations in plasma of As3mt KO mice treated with 25 ppm As III were only about 3-fold higher than those in mice treated with 1 ppm As III . For each drinking water As III concentration, summed arsenical concentrations in plasma of WT mice were higher than those found in As3mt KO mice. These differences between WT mice and As3mt KO mice were statistically significant (95% CI, p < 0.05) at the 10 and 25 ppm dosage levels. The predominant arsenic species in plasma of WT mice was dimethyl arsenic (DMA), whereas in KO mice, iAs predominated.
RESULTS
For either As3mt genotype, summed arsenical concentrations in RBCs from mice increased in a dosage-dependent manner (Fig.  1c) . At each As III dosage level, summed arsenical concentrations for RBCs from As3mt KO mice were significantly higher than for RBCs from WT mice (95% CI, p < 0.05). The predominant arsenic species in RBC from As3mt KO mice was iAs.
As3mt genotype also affected the relative fractional concentrations of methylated arsenical species in plasma (Fig. 1b) and RBCs (Fig. 1d) . For both plasma and RBCs, methylated arsenicals accounted for a significantly smaller percentage of the As burden in As3mt KO mice than in WT mice. iAs was the major arsenic species in both plasma and RBC of the KO mice. Mono-, di-, and trimethylated arsenicals were present in the plasma of As3mt KO mice, albeit at lower levels than in the plasma of WT mice. In RBCs from As3mt KO mice, mono-and dimethylated arsenicals accounted for a small percentage of the As burden. Mono-, di-, and trimethylated arsenicals were Because the As3mt genotype could independently affect the distribution of arsenicals among tissues, the relations were examined between the concentrations of inorganic or methylated arsenicals in plasma and RBCs. Arsenicals in plasma are the proximal source for uptake into RBCs; hence, a change in the concentration of an arsenic species in plasma should be reflected by a change in its concentration in RBCs. Figure 2 shows that in both As3mt KO or WT mice, there were linear relations between the concentration of each arsenical in plasma and RBCs, although the concentration range for the arsenicals differed between genotypes.
As3mt genotype affected summed arsenical concentrations and patterns of metabolites present in liver, kidneys, and lungs of WT and As3mt KO mice that received 1-25 ppm As as As III in drinking water for 33 days (Fig. 3) . For both genotypes, summed arsenical concentrations in these tissues increased as the concentration of As III in drinking water increased. At each As III dosage level, summed arsenical concentrations in each tissue were higher in As3mt KO mice than in WT mice. The differences between genotypes were statistically significant for all tissues, as shown in Figs. 3a-3c . In WT mice, methylated species accounted for most of the tissue As burden. Higher summed arsenical concentrations in tissues of As3mt KO mice reflected the preponderant contribution of iAs to tissue burdens, although small amounts of methylated arsenicals were detected in livers and lungs from these mice.
Effects of As3mt genotype on the fractional distribution of arsenicals in kidney, liver, and lung can be illustrated using data from WT and As3mt KO mice that were dosed with 25 ppm As as As III in drinking water for 33 days (Fig. 3d) . In tissues from As3mt KO mice, iAs is the predominant arsenical; methylated arsenicals account for no more than 10% of the tissue arsenical concentration. In tissues of WT mice, iAs accounted for up to about 50% in liver, 10% in kidney, and was not detectable in lung.
DISCUSSION
This study compared metabolism and tissue dosimetry of iAs in WT and As3mt KO mice exposed to 1, 10, or 25 ppm of As as As III in drinking water. Because knockout of the As3mt gene effectively blocks tissue expression of arsenic (þ3 oxidation state) methyltransferase, the enzyme that catalyzes As methylation (Drobná et al., 2009) , As3mt KO mice exhibit a unique phenotype for As methylation. This phenotype resulted in higher summed concentrations of arsenicals in RBCs, liver, kidney, and lung than in WT mice. In all tissues of As III -treated As3mt KO mice, iAs was the predominant arsenical. Recent studies in As3mt KO and WT mice given single or repeated oral doses (Hughes et al., 2003) of As V have also shown that KO of this gene in mice resulted in high tissue accumulation of iAs and reduced the rate of As clearance from tissues and whole body (Drobná et al., 2009; Hughes et al., 2010) . In WT and As3mt KO mice brought to steady state whole body burdens of As by repeated oral doses of As V , summed arsenical concentrations in liver, kidney, and lung were significantly greater in As3mt KO mice than in WT mice (Hughes et al., 2010) . Given the duration of exposure in this study (Hughes et al., 2003) , it is likely that whole body steady state As burdens were attained in both WT and As3mt KO mice after 33 days of exposure to As III in drinking water. Concordant findings of elevated tissue levels of iAs in As3mt ARSENIC METABOLISM AND TISSUE DOSIMETRY 323 KO mice treated with As III or As V are consistent with earlier work indicating the methylated arsenicals are cleared more rapidly than iAs (Buchet et al., 1981) . Altered tissue distribution and retention of arsenicals in tissues of As3mt KO mice treated with As III or As V are also consistent with earlier animal studies showing that altered AdoMet availability affected capacity for conversion of iAs to methylated metabolites and changed tissue distribution patterns for arsenicals from those found in unaltered animals (Marafante and Vahter, 1984; Marafante et al., 1985; Vahter and Marafante, 1987) . Furthermore, similar patterns of elevated tissue iAs concentrations in As3mt KO mice treated with As III or As V suggest that retention of As in tissues was not affected by the oxidation state of the administered arsenical but rather by the lack of capacity to form methylated arsenicals in reactions catalyzed by As3mt. Thus, under conditions of exposure that produce steady state tissue concentrations, redox interconversion of As III and As V that occurs in the course of metabolism may obviate differences in short-term tissue As distribution that are found after administration of As III or As V (Lerman and Clarkson, 1983; Vahter and Marafante, 1983) .
As in earlier studies of the retention and distribution of As in As V -treated mice (Drobná et al., 2009; Hughes et al., 2010) , knockout of the As3mt gene did not eliminate methylated arsenical metabolites in blood and tissues of As3mt KO mice exposed to As III in drinking water. The origin of methylated arsenicals in the tissues of As3mt KO mice remains to be clarified. Methylated arsenicals in tissues of As3mt KO mice could be produced by reactions catalyzed by other, as yet uncharacterized, As methyltransferases encoded in the mouse genome. Alternatively, methylated metabolites of iAs found in tissues of As3mt KO mice may be produced by the microbiota of the mouse gastrointestinal tract. In vitro, the anaerobic microbiota of mouse cecum converts As , and TMAO (Hall et al., 1997; Kubachka et al., 2009; Pinyayev et al., 2011) . The preabsorptive metabolism of arsenite could affect the bioavailability of ingested arsenite and the pattern of distribution of arsenicals among tissues.
The patterns for the distribution of inorganic arsenite and its methylated metabolites among the tissues of WT and As3mt KO mice can be considered in terms of a conceptual model for arsenic metabolism (Thomas, 2007) . In this approach, processes including influx, efflux, transformation, and macromolecular interactions determine the extent of cellular accumulation of arsenicals and the effects associated with the presence of these agents in the cell. Data on the relation between concentrations of inorganic, mono-, or dimethyl arsenicals in plasma and RBCs from WT and As3mt KO mice indicate that the As3mt genotype does not affect the capacity of RBCs to accumulate arsenicals that are present in the plasma; that is, for either genotype, a change in the concentration of an arsenical species in plasma is accompanied by a change in the concentration of that species in RBCs. Although this analysis does not provide insight into molecular processes involved in influx or efflux or arsenicals or transformative processes or molecular interactions that occur in cells, it suggests that in sum these processes are not affected by the silencing of As3mt gene expression. However, complementary molecular tools can be used to study the roles of transporters involved in cellular fluxes of pentavalent or trivalent arsenicals (Carbrey et al., 2009; Jiang et al., 2010; Villa-Bellosta and Sorribas, 2010) . For example, the role of aquaporin-9 (AQP-9), a permease that mediates cellular As III flux (Shinkai et al., 2009) , has been demonstrated in AQP-9 null mice that are more sensitive to As III toxicity than are AQP-9 WT mice. Similarly, altered molecular interactions can affect the accumulation of arsenicals in tissues. Increased accumulation and prolonged clearance of As from the blood of rats is related to a speciesspecific difference Lu et al., 2004 Lu et al., , 2007 Naranmandura et al., 2007) in the binding of DMA III to Cys13a of rat hemoglobin in RBCs (Lu et al., 2004 (Lu et al., , 2007 . Studies involving use of mice in which two critical genes have been knocked out (e.g., As3mt and AQP-9) would permit examination of how the interactions between the molecular processes involved in arsenic metabolism affects both the kinetic and dynamic behavior of arsenicals. The As methylation phenotype associated with knockout of the As3mt gene in mice has functional consequences in terms of toxicity associated with exposure to iAs. Differences between As3mt KO and WT mice in pattern and extent of tissue accumulation of arsenicals are germane to interpretation of results from studies showing that exposure to As III in drinking water produced more extensive cytotoxicity and regenerative hyperplasia in the urothelium of As3mt KO mice than in WT mice (Yokohira et al., 2010 (Yokohira et al., , 2011 . Findings of the current and other studies of tissue distribution of arsenicals in As3mt KO mice show that diminished capacity to methylate arsenic is associated with elevated concentrations of iAs in tissues (Drobná et al., 2009; Hughes et al., 2010) . Accumulation of iAs in target tissues such as urinary bladder may be sufficient to account for structural alterations seen in affected tissues. That is, a phenotype of increased susceptibility to As-induced urothelial cell injury in As3mt KO mice may be due to altered retention of As in the target tissue, not to a change in the susceptibility of the target tissue to As-induced injury. Because the capacity for As methylation is greatly reduced, but not eliminated, in As3mt KO mice, it should be possible to determine tissue dosimetry for each of the metabolites formed in As3mt-catalyzed metabolism of arsenicals and to develop dose-response relations for these metabolites and effects on cell structure and function that underlie the activities of arsenicals as toxicants and carcinogens. This approach may be especially valuable in evaluating the actions of methylated metabolites (e.g., methylarsonous acid), which are likely to mediate some of the toxic responses associated with chronic exposure to iAs.
In summary, silencing of As3mt gene expression in mice markedly reduces the capacity to methylate iAs. This altered phenotype for As methylation results in accumulation of high concentrations of iAs in many tissues, including urinary bladder, a target organ for this metalloid. The As3mt KO mouse is a valuable model for exploring the role of arsenic methylation in organ-specific toxicity induced by arsenic exposure. 
